JOURNAL ARTICLE

Tocilizumab: Still of Limited Benefit for Patients with COVID-19 Pneumonia

Richard T. Ellison

Year: 2021 Journal:   Journal watch Vol: 2021   Publisher: Massachusetts Medical Society

Abstract

Given the acute clinical deterioration that can develop in association with high serum interleukin-6 levels during the second week of COVID-19's

Keywords:
Tocilizumab Medicine Coronavirus disease 2019 (COVID-19) Pneumonia Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 2019-20 coronavirus outbreak Intensive care medicine Viral pneumonia Pandemic Virology Internal medicine Outbreak Infectious disease (medical specialty) Disease

Metrics

0
Cited By
0.00
FWCI (Field Weighted Citation Impact)
0
Refs
0.00
Citation Normalized Percentile
Is in top 1%
Is in top 10%

Topics

COVID-19 Clinical Research Studies
Health Sciences →  Medicine →  Infectious Diseases
Long-Term Effects of COVID-19
Health Sciences →  Medicine →  Neurology
SARS-CoV-2 and COVID-19 Research
Health Sciences →  Medicine →  Infectious Diseases

Related Documents

JOURNAL ARTICLE

Not all Patients with Severe/Critical COVID-19 Pneumonia Benefit from Tocilizumab

Abdul Rehman ArshadBilal SaeedImran Mahmood Khan

Journal:   Pakistan Armed Forces Medical Journal Year: 2025 Vol: 75 (4)Pages: 626-630
© 2026 ScienceGate Book Chapters — All rights reserved.